Jesse I Treu - Net Worth and Insider Trading
Jesse I Treu Net Worth
The estimated net worth of Jesse I Treu is at least $113 Million dollars as of 2024-04-26. Jesse I Treu is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $54 Million. Jesse I Treu is the Director of Veracyte Inc and owns about 1,234,930 shares of Veracyte Inc (VCYT) stock worth over $24 Million. Jesse I Treu is also the 10% Owner of Zogenix Inc and owns about 825,323 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Besides these, Jesse I Treu also holds Aldeyra Therapeutics Inc (ALDX) , Esperion Therapeutics Inc (ESPR) , Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Orexigen Therapeutics Inc (OREXQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) . Details can be seen in Jesse I Treu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jesse I Treu has not made any transactions after 2019-03-26 and currently still holds the listed stock(s).
Transaction Summary of Jesse I Treu
Jesse I Treu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jesse I Treu owns 31 companies in total, including Aldeyra Therapeutics Inc (ALDX) , Obalon Therapeutics Inc (OBLN) , and Adynxx Inc (ADYX) among others .
Click here to see the complete history of Jesse I Treu’s form 4 insider trades.
Insider Ownership Summary of Jesse I Treu
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALDX | Aldeyra Therapeutics Inc | 2019-03-26 | director & 10 percent owner |
OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
ADYX | Adynxx Inc | 2019-05-03 | 10 percent owner |
VCYT | Veracyte Inc | 2019-03-04 | director & 10 percent owner |
BNGO | Bionano Genomics Inc | 2018-08-21 | 10 percent owner |
DRNA | Dicerna Pharmaceuticals Inc | 2017-12-18 | 10 percent owner |
OCRX | Ocera Therapeutics Inc | 2017-12-11 | 10 percent owner |
TNDM | Tandem Diabetes Care Inc | 2013-11-13 | director & 10 percent owner |
RGDO | Regado Biosciences Inc | 2016-11-01 | 10 percent owner |
CLCD | CoLucid Pharmaceuticals Inc | 2016-09-09 | 10 percent owner |
EVOK | Evoke Pharma Inc | 2013-09-24 | 10 percent owner |
SNDX | Syndax Pharmaceuticals Inc | 2016-03-02 | 10 percent owner |
GKOS | Glaukos Corp | 2015-06-24 | 10 percent owner |
LIFE | aTyr Pharma Inc | 2015-05-06 | 10 percent owner |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 10 percent owner |
EVFM | Evofem Biosciences Inc | 2014-11-19 | 10 percent owner |
ATRA | Atara Biotherapeutics Inc | 2014-10-15 | 10 percent owner |
OTIC | Otonomy Inc | 2014-08-12 | 10 percent owner |
MRNS | Marinus Pharmaceuticals Inc | 2014-07-31 | 10 percent owner |
AKAOQ | Achaogen Inc | 2014-03-17 | 10 percent owner |
ALIM | Alimera Sciences Inc | 2011-06-02 | 10 percent owner |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 10 percent owner |
ACHN | Achillion Pharmaceuticals Inc | 2013-01-18 | 10 percent owner |
CPXX | Celator Pharmaceuticals Inc | 2013-01-14 | 10 percent owner |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 10 percent owner |
ZGNX | Zogenix Inc | 2011-09-16 | 10 percent owner |
PRTK | Paratek Pharmaceuticals Inc | 2006-05-09 | 10 percent owner |
VNDA | Vanda Pharmaceuticals Inc | 2006-04-12 | 10 percent owner |
SNMX | Senomyx Inc | 2004-06-25 | 10 percent owner |
NUVA | NuVasive Inc | 2004-05-12 | 10 percent owner |
RSLS | Reshape Lifesciences Inc | 2016-10-05 | 10 percent owner |
Jesse I Treu Latest Holdings Summary
Jesse I Treu currently owns a total of 11 stocks. Among these stocks, Jesse I Treu owns 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) as of August 20, 2010, with a value of $54 Million and a weighting of 48.04%. Jesse I Treu owns 1,234,930 shares of Veracyte Inc (VCYT) as of March 4, 2019, with a value of $24 Million and a weighting of 21.1%. Jesse I Treu also owns 825,323 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 19.48%. The other 8 stocks Aldeyra Therapeutics Inc (ALDX) , Esperion Therapeutics Inc (ESPR) , Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Orexigen Therapeutics Inc (OREXQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) have a combined weighting of 11.38% among all his current holdings.
Latest Holdings of Jesse I Treu
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACHN | Achillion Pharmaceuticals Inc | 2010-08-20 | 8,032,129 | 6.76 | 54,297,192 |
VCYT | Veracyte Inc | 2019-03-04 | 1,234,930 | 19.31 | 23,846,498 |
ZGNX | Zogenix Inc | 2010-11-29 | 825,323 | 26.68 | 22,019,618 |
ALDX | Aldeyra Therapeutics Inc | 2019-03-26 | 1,885,854 | 3.93 | 7,411,406 |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 2,102,188 | 1.90 | 3,994,157 |
ALIM | Alimera Sciences Inc | 2011-06-02 | 279,297 | 3.49 | 974,747 |
OCRX | Ocera Therapeutics Inc | 2013-07-15 | 246,386 | 1.79 | 441,031 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,041,950 | 0.02 | 45,629 |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 301,806 | 0.01 | 1,600 |
NOVCQ | Novation Companies Inc | 2006-05-15 | 1,062,474 | 0.00 | 106 |
RGDO | Regado Biosciences Inc | 2013-08-27 | 2,603,208 | 0.00 | 0 |
Holding Weightings of Jesse I Treu
Jesse I Treu Form 4 Trading Tracker
According to the SEC Form 4 filings, Jesse I Treu has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on August 20, 2010, which brought Jesse I Treu around $0.
According to the SEC Form 4 filings, Jesse I Treu has made a total of 0 transactions in Veracyte Inc (VCYT) over the past 5 years. The most-recent trade in Veracyte Inc is the sale of 1,052,151 shares on March 4, 2019, which brought Jesse I Treu around $21 Million.
According to the SEC Form 4 filings, Jesse I Treu has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost Jesse I Treu around $9 Million.
More details on Jesse I Treu's insider transactions can be found in the Insider Trading History of Jesse I Treu table.Insider Trading History of Jesse I Treu
- 1
Jesse I Treu Trading Performance
GuruFocus tracks the stock performance after each of Jesse I Treu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jesse I Treu is 13.44%. GuruFocus also compares Jesse I Treu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jesse I Treu within 3 months outperforms 5 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jesse I Treu's insider trading performs compared to the benchmark.
Performance of Jesse I Treu
Average Return
-10.03%
Outperforming Transactions
29%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 13.79 | 13.44 | 18.78 | -10.03 | -21.41 | -11.18 |
Relative Return to S&P 500(%) | 10.5 | 8.42 | 10.72 | -22.53 | -32.48 | -21.59 |
Jesse I Treu Ownership Network
Ownership Network List of Jesse I Treu
Ownership Network Relation of Jesse I Treu
Jesse I Treu Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
Jesse I Treu is the director & 10 percent owner of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Development Officer Stephen Machatha , and director & President and CEO Todd C Brady .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Jesse I Treu made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 41,305 shares made by Stephen Machatha , and a net sale of 26,402 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
Jesse I Treu Mailing Address
Above is the net worth, insider trading, and ownership report for Jesse I Treu. Currently GuruFocus does not have mailing address information for Jesse I Treu.